This
1 hour module presented by Dr Catherine Tang, aims to explain the evidence
basis for treatment recommendations in indolent Non-Hodgkin Lymphoma (iNHL),
the indications for treatment in iNHL, including the prognostic factors in
different subtypes, the role of transplantation in different iNHL subtypes. Featuring
three case studies, this module provides a key summary of Low Grade Non-Hodgkin
Lymphoma and the evolving role of novel therapies.
Dr Catherine Tang
MBBS FRACP FRCPA
Consultant Haematologist
Wellington Hospital, New Zealand
The program is endorsed by the Royal Australian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA) Committee for Joint College training in Haematology (CJCT) and the Haematology Society of Australia and New Zealand (HSANZ).
Fellows of the RACP and RCPA can claim CPD hours.
At the end of this module, you will be better able to: